Apixaban versus warfarin in patients with atrial fibrillation

Christopher Granger, John Alexander, John McMurray, Renato Lopes, Elaine Hylek, Michael Hanna, Hussein Al-Khalidi, Jack Ansell, Dan Atar, Alvaro Avezum, M Bahit, Rafael Diaz, Donald Easton, Justin Ezekowitz, Greg Flaker, David Garcia, Margarida Geraldes, Bernard Gersh, Sergey Golitsyn, Shinya GotoAntonio Hermosillo, Stefan Hohnloser, John Horowitz, Puneet Mohan, Petr Jansky, Basil Lewis, Jose Lopez-Sendon, Prem Pais, Alexander Parkhomenko, Freek Verheugt, Jun Zhu, Lars Wallentin, M Vico, I Mackinnon, D Vogel, A. Gabito, A Cassettari, C Zaidman, O Montana, A. Hrabar, H Jure, H Lastiri, C. Poy, A Caccavo, C Cuneo, H Colombo, F Rolandi, A Hershson, M Garrido, A Sanchez, M L Bruno, D Piskorz, J Cuadrado, E Hasbani, J Serra, L Cartasegna, P Schygiel, C Muratore, J Marino, M I Sosa Liprandi, R. A. Guerrero, H Ramos, D Mercado, L Guzmon, C Beneitez, J Estepo, R. Torrijos, E Retyk, N Vita, H Luciardi, M Casey, S Orlando, M B Labarta, D Santos, J Amerena, P Purnell, J Horowitz, H Salem, A Lui, L Zimmet, S Roger, Fred De Looze, R Lehman, B Jackson, D Ashby, W Heddle

Research output: Contribution to journal › Article › peer-review

7976 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Apixaban versus warfarin in patients with atrial fibrillation'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science